Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Monte Rosa Therapeutics to Present Pipeline Update and Release Fourth Quarter and Full Year 2024 Financial Results on March 20, 2025
-
Monte Rosa Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
-
Monte Rosa Therapeutics Provides Corporate Update and Key Anticipated Milestones for 2025
-
Monte Rosa Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Monte Rosa Therapeutics Appoints Dr. Eric A. Hughes to Board of Directors
-
Monte Rosa Therapeutics Announces Closing of Global License Agreement with Novartis
-
Monte Rosa Therapeutics Presents Preclinical Data at the 2024 San Antonio Breast Cancer Symposium on the Potential of its CDK2-directed Molecular Glue Degr
-
Monte Rosa Therapeutics Provides Development Progress Update for Ongoing MRT-2359 Phase 1/2 Study in Patients with MYC-driven Solid Tumors
-
Monte Rosa Therapeutics to Participate in the Piper Sandler Healthcare Conference
-
Monte Rosa Therapeutics to Participate in the Jefferies London Healthcare Conference